Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at ...
3d
Current heart attack screening tools fail to identify half the people who are at risk, study shows
Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at ...
The FDA has granted Fast Track designation to VS-041, an investigational therapy for the treatment of heart failure with preserved ejection fraction.
Mount Sinai study shows that traditional risk scores and symptoms such as chest pain should not be solely relied upon to ...
Reintroduction of the Cyclin A2 gene enables adult human cardiomyocytes to divide, producing functional daughter cells and promoting heart repair. The therapy uses a replication-deficient adenoviral ...
Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback